Search Results - "Dayde, D"

Correction to: p14ARF inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway by Ozenne, P., Dayde, D., Brambilla, E., Eymin, B., Gazzeri, S.

“…A Correction to this paper has been published: https://doi.org/10.1038/s41388-021-01653-4…”
Get full text

Nuclear trafficking of EGFR by Vps34 represses Arf expression to promote lung tumor cell survival by Dayde, D, Guerard, M, Perron, P, Hatat, A-S, Barrial, C, Eymin, B, Gazzeri, S

“…Epidermal growth factor receptor (EGFR) is a cell surface receptor that has an essential role in cell proliferation and survival, and overexpression of EGFR is…”
Get full text

p14(ARF) inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway by Ozenne, P, Dayde, D, Brambilla, E, Eymin, B, Gazzeri, S

“…Epidermal growth factor receptor (EGFR) stimulates proliferative and survival signals. Activating mutations of EGFR are involved in the aetiology and…”
Get full text

Progastrin, a new blood biomarker for the diagnostic and therapeutic monitoring, in gastro-intestinal cancers: A BIG-RENAPE project by You, B., Kepenekian, V., Prieur, A., Caceres, M., Payen-Gay, L.F., Liaud, P., Flaceliere, M., Tod, M., Villeneuve, L., Bibeau, F., Bernard, L., Jourdan-Enfer, P., Medeghri, N., Dayde, D., Calattini, S., Freyer, G., Maucort-Boulch, D., Joubert, D., Glehen, O.

Get full text

496: Nuclear EGFR controls the expression of the ARF tumor suppressor by Dayde, D, Ozenne, P, Perron, P, Barrial, C, Eymin, B, Gazzeri, S

Get full text

321 An EGFR/ARF Cross-talk Controls the Growth of Lung Adenocarcinoma Cells With Mutant EGFR by Gazzeri, S, Ozenne, O, Dayde, D, Perron, P, Barrial, C, Brambilla, E, Eymin, B

Get full text

Correction to: p14.sup.ARF inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway by Ozenne, P, Dayde, D, Brambilla, E, Eymin, B, Gazzeri, S

“…A Correction to this paper has been published:…”
Get full text

468 Role of the p14ARF tumour suppressor in EGFR-mediated growth control of lung cancer cells by Ozenne, P, Dayde, D, Perron, P, Barrial, C, Brambilla, C, Brambilla, E, Eymin, B, Gazzeri, S

Get full text

614P Tolerance and preliminary efficacy of intraperitoneal (IP) nivolumab after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients (pts) with advanced ovarian carcinoma: A phase I study with expansion cohort (ICONIC) by Corbaux, P., You, B., Kepenekian, V., Bakrin, N., Gelot, A., Dayde, D., Sajous, C., Lamuraglia, M., Peron, J., Glehen, O., Freyer, G.

Get full text

Correction to: p14 ARF inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway by Ozenne, P, Dayde, D, Brambilla, E, Eymin, B, Gazzeri, S

Get full text

A modification of cAMP compartmentation is involved in the doxorubicin-induced cardiotoxicity by Dayde, D., Belhadef, A., Barthe, M., Lefebvre, F., Mika, D., Fischmeister, R., Morel, E.

Get full text

Feasibility of a screening and prevention procedure for risks associated with dysphagia in older patients in geriatric units: the DYSPHAGING pilot study protocol by Durlach, Olivier, Tripoz-dit-Masson, Stéphanie, Massé-Deragon, Nicolas, Subtil, Fabien, Niasse-Sy, Zeinabou, Herledan, Chloé, Guittard, Laure, Goldet, Karine, Merazga, Salima, Chabert, Margaux, Suel, Anne, Dayde, David, Merdinian, Marion, Falandry, Claire

“…BackgroundDysphagia, particularly sarcopenic dysphagia, is frequent in frail older patients. Sarcopenic dysphagia is a swallowing disorder caused by…”
Get full text

p14.sup.ARF inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway by Ozenne, P, Dayde, D, Brambilla, E, Eymin, B, Gazzeri, S

“…Epidermal growth factor receptor (EGFR) stimulates proliferative and survival signals. Activating mutations of EGFR are involved in the aetiology and…”
Get full text

p14ARF inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway by Ozenne, P, Dayde, D, Brambilla, E, Eymin, B, Gazzeri, S

“…Epidermal growth factor receptor (EGFR) stimulates proliferative and survival signals. Activating mutations of EGFR are involved in the aetiology and…”
Get full text

p14 super(ARF) inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway by Ozenne, P, Dayde, D, Brambilla, E, Eymin, B, Gazzeri, S

“…Epidermal growth factor receptor (EGFR) stimulates proliferative and survival signals. Activating mutations of EGFR are involved in the aetiology and…”
Get full text

inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway by Ozenne, P, Dayde, D, Brambilla, E, Eymin, B, Gazzeri, S

“…Epidermal growth factor receptor (EGFR) stimulates proliferative and survival signals. Activating mutations of EGFR are involved in the aetiology and…”
Get full text

Impact of a food enhancement strategy on food appreciation in cancer patients undergoing chemotherapy treatment by Dougkas, A., Drareni, K., Roche, M., Bruyas, A., Roux, P., Fingal, C., Dayde, D., Bensafi, M., Nazare, J.A., Fournel, A., Labrosse, H., Farsi, F., Mourier, V., Riche, B., Giboreau, A.

Get full text

119PProgastrin, a new blood biomarker for the diagnostic and therapeutic monitoring, in gastro-intestinal cancers: A BIG-RENAPE project by You, B, Kepenekian, V, Prieur, A, Caceres, M, Payen-Gay, L F, Liaud, P, Flaceliere, M, Tod, M, Villeneuve, L, Bibeau, F, Bernard, L, Jourdan-Enfer, P, Medeghri, N, Dayde, D, Calattini, S, Freyer, G, Maucort-Boulch, D, Joubert, D, Glehen, O

Get full text

Risk factors associated with day-30 mortality in patients over 60 years old admitted in ICU for severe COVID-19: the Senior-COVID-Rea Multicentre Survey protocol by Falandry, C., Malapert, A., Roche, M., Subtil, F., Berthiller, J., Boin, C., Dubreuil, J., Ravot, C., Bitker, L., Abraham, P., Collange, V., Balança, B., Goutte, S., Guichon, C., Gadea, E., Argaud, L., Dayde, D., Jallades, L., Lepape, A., Pialat, J. B., Friggeri, A., Thiollière, F.

“…INTRODUCTION: With the spread of COVID-19 epidemic, health plans must be adapted continuously. There is an urgent need to define the best care courses of…”
Get full text

Développement et validation d’un questionnaire d’évaluation de la Qualité de Vie Alimentaire (QVA) chez les patients atteints de cancer by Drareni, K., Mercier, C., Dougkas, A., Roux, P., Fingal, C., Labrosse, H., Farsi, F., Dayde, D., Roche, M., Nazare, J.-A., Bruyas, A., Maucort-Boulch, D., Fournel, A., Bensafi, M., Mourier, V., Giboreau, A.

“…Le suivi des aspects psychosociaux, émotionnels et hédoniques du comportement alimentaire est important pour comprendre la détresse des patients atteints de…”
Get full text